The role of VEGFR-TKIs in the treatment of advanced RCC alone or in combination

Episode 1 November 30, 2021 00:20:49
The role of VEGFR-TKIs in the treatment of advanced RCC alone or in combination
COR2ED Medical Education
The role of VEGFR-TKIs in the treatment of advanced RCC alone or in combination

Nov 30 2021 | 00:20:49

/

Show Notes

Prof. Thomas Powles, a Medical Oncologist from Barts Cancer Centre in the UK and Prof. Georg Hutterer, a Urologist from the Medical University of Graz, Austria, discuss the role of VEGFR-TKIs in the treatment of advanced renal cell carcinoma (RCC) alone or in combination with immunotherapy.

In this podcast, by COR2ED Medical Education, the two experts discuss key trials (CHECKMATE 214, KEYNOTE 426, CHECKMATE 9ER and CLEAR) which have led to recent updates to the ESMO and EAU treatment guidelines for RCC. Combination treatment with either VEGFR targeted therapy plus a PD-1 or CTLA-4 inhibitor in the first-line setting is discussed as well as VEGFR-TKI monotherapy options at the time of disease progression.

They also focus on how to manage treatment toxicity whilst trying to optimise treatment outcomes and preserving patients’ quality of life as well as the use of biomarkers and risk stratification models.

Other Episodes

Episode 12

April 26, 2023 00:21:09
Episode Cover

Treatment sequencing in advanced mCRC patients

COR2ED Medical Education: This podcast episode discusses treatment sequencing in advanced metastatic colorectal cancer (mCRC) patients, third line and beyond.  Dr Shubham Pant from...

Listen

Episode 2

July 22, 2021 00:22:14
Episode Cover

Women & Girls Bleed Too: Diagnosing Bleeding Disorders - Episode 2

In this second episode of the podcast series Women and Girls Bleed Too, Haematologist Dr. Roseline d’Oiron (Reference Centre for Haemophilia and RBD, Bicêtre...

Listen

Episode 2

July 11, 2022 00:23:31
Episode Cover

Shared decision-making in nmCRPC

Shared decision-making in nmCRPC: Treatment considerations to maintain quality of life COR2ED Medical Education: Brenda Martone, a nurse practitioner at Northwestern Medicine in Chicago...

Listen